Cargando…

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions

O6-methylguanine-methyltransferase (MGMT) promoter methylation status has prognostic and, in the subpopulation of elderly patients, predictive value in newly diagnosed glioblastoma. Therefore, knowledge of the MGMT promoter methylation status is important for clinical decision-making. So far, MGMT t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bienkowski, Michal, Berghoff, Anna S., Marosi, Christine, Wöhrer, Adelheid, Heinzl, Harald, Hainfellner, Johannes A., Preusser, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542181/ https://www.ncbi.nlm.nih.gov/pubmed/26295302 http://dx.doi.org/10.5414/NP300904

Ejemplares similares

Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma
por: Preusser, Matthias, et al.
Publicado: (2014)

Clinical Neuropathology Practice Guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers
por: Berghoff, Anna S., et al.
Publicado: (2013)

Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients – yes, but how?
por: Berghoff, Anna S., et al.
Publicado: (2012)

Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers
por: Berghoff, Anna Sophie, et al.
Publicado: (2012)

Clinical neuropathology practice guide 1-2013: Molecular subtyping of glioblastoma: ready for clinical use?
por: Woehrer, Adelheid, et al.
Publicado: (2013)

Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
por: Preusser, Matthias, et al.
Publicado: (2015)

MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas
por: Micko, Alexander S. G., et al.
Publicado: (2017)

Response to imatinib as a function of target kinase expression in recurrent glioblastoma
por: Hassler, Marco Ronald, et al.
Publicado: (2014)

Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma
por: Li, Mingxiao, et al.
Publicado: (2021)

Open questions: some unresolved issues in biodiversity
por: Magurran, Anne E
Publicado: (2013)

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
por: Quillien, Véronique, et al.
Publicado: (2014)

Prognostic Role of Methylation Status of the MGMT Promoter Determined Quantitatively by Pyrosequencing in Glioblastoma Patients
por: Kim, Dae Cheol, et al.
Publicado: (2016)

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
por: Villani, Veronica, et al.
Publicado: (2015)

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma
por: Mair, Maximilian J., et al.
Publicado: (2020)

Congenital Lung Malformations: Unresolved Issues and Unanswered Questions
por: Annunziata, Federica, et al.
Publicado: (2019)

Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas
por: Haberler, Christine, et al.
Publicado: (2014)

Molecular diagnostic testing of diffuse gliomas in the real-life setting: A practical approach
por: Bieńkowski, Michał, et al.
Publicado: (2018)

Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience
por: Baur, Martina, et al.
Publicado: (2010)

MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals
por: Micko, Alexander S. G., et al.
Publicado: (2018)

The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
por: Zhao, Hailong, et al.
Publicado: (2016)

Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients
por: Estival, Anna, et al.
Publicado: (2019)

Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma
por: Mair, Maximilian J., et al.
Publicado: (2021)

MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas
por: Hosoya, Tomohiro, et al.
Publicado: (2022)

Unresolved questions in the zoonotic transmission of MERS
por: Peiris, Malik, et al.
Publicado: (2022)

Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling
por: Furtner, Julia, et al.
Publicado: (2019)

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
por: Håvik, Annette Bentsen, et al.
Publicado: (2012)

Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial
por: Quillien, Véronique, et al.
Publicado: (2016)

Direct or indirect endothelial damage? An unresolved question
por: Basta, Giuseppina
Publicado: (2021)

Emergence agitation: current knowledge and unresolved questions
por: Lee, Seok-Jin, et al.
Publicado: (2020)

Preterm birth, an unresolved issue
por: Belizán, Jose M, et al.
Publicado: (2013)

Unresolved basic issues in hepatology
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Clinical neuropathology practice news 2-2012: BRAF V600E testing
por: Capper, David, et al.
Publicado: (2012)

Clinical Neuropathology teaching case 4-2015: Heterogenous brain pathologies temporally and spatially coinciding in limbic regions
por: Kovacs, Gabor G., et al.
Publicado: (2015)

LAG-3 expression in the inflammatory microenvironment of glioma
por: Mair, Maximilian J., et al.
Publicado: (2021)

Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)

Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS)
por: Woehrer, Adelheid, et al.
Publicado: (2017)

Aquaporin water channels: unanswered questions and unresolved controversies
por: Agre, Peter, et al.
Publicado: (1995)

Unresolved questions about the treatment of COVID-19 with corticosteroids()
por: Corral-Gudino, Luis, et al.
Publicado: (2021)

Aldosterone and the Heart: Still an Unresolved Issue?
por: Catena, Cristiana, et al.
Publicado: (2014)

COVID-19: Some unresolved issues
por: Gómez-Pavón, Javier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h9vcghog4igrh03h9hllkc5i89